SOPH

SOPHiA GENETICS SA

SOPHiA GENETICS SA (SOPH) has 15 SEC Form 4 filings (26 transaction rows) in the rolling window, disclosed by 8 distinct insiders. Most recent filing: Jul 14, 2026.

The most active filer is Executive Chairman Camblong Jurgi with 7 filings. Insiders have net sold $1.3M over the trailing 6 months.

  • Industry:Medical - Healthcare Information Services
  • CEO:Jurgi Camblong
  • Employees:423
  • HQ:Rolle, CH
  • IPO:2021-07-23

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.3M

reported sales (SEC code S)

Unique Insiders

8

in the rolling window

Market Cap

$389.0M

latest known value

Source
Sale$48KJul 14SEC ↗
Sale$29KJul 14SEC ↗
Sale$23KJul 14SEC ↗
Sale$93KJul 8SEC ↗
Puylaert KevinFirst filing
Sale$1KJul 7SEC ↗
Valente ManuelaFirst filing
Sale$21KJul 7SEC ↗
Sale$118KJul 7SEC ↗
Xu ZhenyuFirst filing
Sale$38KJul 7SEC ↗
Verma AbhimanyuFirst filing
Sale$27KJul 7SEC ↗
Sale$38KJul 7SEC ↗
Muken RossFirst filing
Sale$51KJul 7SEC ↗
CARDOZA GEORGEFirst filing
Sale$8KJul 7SEC ↗
Sale$108KJul 1SEC ↗
Sale$399KJul 1SEC ↗
Camblong JurgiFirst filing
Sale$8KJun 29SEC ↗
Camblong JurgiFirst filing
Sale$290KJun 29SEC ↗
Menu PhilippeFirst filing
Sale$25KJun 1SEC ↗

Related companies

SOPHiA GENETICS SA is in the Technology sector.